Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
antiepileptic, Baeringer, bioavailability, Blueprint, clarifying, College, cord, Dalhousie, debenture, demand, desvenlafaxine, diabetic, endorsed, ethical, fibromyalgia, fraud, graduate, graduated, Halifax, inhibitor, Ira, Keppra, levetiracetam, Lyrica, mandatory, Mary, methodology, Mine, neuralgia, neuropathic, neuropathy, norepinephrine, onset, peripheral, postherpetic, pregabalin, Pristiq, reuptake, revalidate, School, serotonin, slightly, spinal, Tekla, title, Trillium, William
Removed:
actively, add, administer, BioMax, bloodstream, British, Cdn, chosen, CIBC, collaborating, compatible, continuation, continuity, conventional, decreased, deliver, designing, discounted, escrow, examining, exchanged, exploitation, focusing, fourth, gave, Graham, infection, intelligent, manipulation, Mellon, Neil, niche, North, pilot, readily, removal, robust, safer, staffing, stronger, substantiated, target, Touche, unaware, underlie, VIL, VUS, working
Filing tables
Filing exhibits
IPCIF similar filings
Filing view
External links
Exhibit 15.1
Deloitte LLP 5140 Yonge Street Suite 1700 Toronto ON M2N 6L7 Canada Tel: 416-601-6150 Fax: 416-601-6151 www.deloitte.ca |
Consent of Independent Registered Chartered Accountants
We consent to the incorporation by reference in Registration Statement No(s). 333-178190 and 333-172796 on Form F-3 of our report dated January 29, 2013, relating to consolidated financial statements of Intellipharmaceutics International Inc. “(the Company”) (which report expresses an unqualified opinion and includes an explanatory paragraph relating to the conditions and events that raise substantial doubt on the Company’s ability to continue as a going concern) appearing in the Form 20-F for the year ended November 30, 2012.
/s/ Deloitte LLP
Independent Registered Chartered Accountants
Licensed Public Accountants
Toronto, Canada
January 31, 2013